Supporting our community through Covid-19
We know that this is a very challenging time for everyone, for many different reasons. If any aspect of the publishing process is worrying you – for example you think you may struggle to meet a pre-determined deadline – please let us know, and we will work out an answer together.
Setting up remote access to RSC content
You can find details about how to access information remotely in this step-by-step guide. The guide will also help if for any reason you have difficulty accessing the content you want.

Molecular Omics publishes high-quality research in the -omics sciences. We welcome scientific research based on the application of any -omics technology and we encourage multi-omics approaches to solving important chemical or biological problems. This includes combining different types of omics platforms encompassing genomics, transcriptomics, proteomics, metabolomics and other specialized areas such as glycomics and lipidomics, as well as innovative bioinformatics approaches.
Robert Moritz - Chair
Institute for Systems Biology, Seattle, USA
Publishing frequency: 6 issues per year
Indexed/abstracted in: MEDLINE, Scopus, Web of Science

A trusted editorial team
Our rigorous peer review process ensures transparency, fairness and balance

Open Access options
We can help you improve the visibility of your work and meet funder mandates

No cost to publish
We don't charge submission, page or colour charges - and we offer free electronic reprints

Pre-prints welcome
We accept submissions of manuscripts that have previously been posted as pre-prints

Copyright is yours
We believe the copyright of your work should always belong to you, so we only ask for a licence to publish it

A focus on community
Because the Royal Society of Chemistry re-invests all surplus back into the global scientific community, you can raise your profile and support international scientific progress at the same time
Scope
Molecular Omics publishes high-quality research from across the -omics sciences.
Topics include, but are not limited to:
- omics studies to gain mechanistic insight into biological processes – for example, determining the mode of action of a drug or the basis of a particular phenotype, such as drought tolerance
- omics studies for clinical applications with validation, such as finding biomarkers for diagnostics or potential new drug targets
- omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques
- studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques. New methods should be proven and demonstrate an advance in the field.
Molecular Omics only accepts articles of high importance and interest that provide significant new insight into important chemical or biological problems. This could be fundamental research that significantly increases understanding or research that demonstrates clear functional benefits.
Papers reporting new results that could be routinely predicted, do not show a significant improvement over known research, or are of interest only to the specialist in the area are not suitable for publication in Molecular Omics.
Chair
Robert Moritz, Institute for Systems Biology, Seattle USA
Associate editor
Michael Washburn, Stowers Institute, Kansas City, USA
Editorial board members
Madan Babu, MRC Laboratory of Molecular Biology, Cambridge, UK
Kate Carroll, The Scripps Research Institute, Florida, USA
Hyungwon Choi, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Benjamin Garcia, Perelman School of Medicine University of Pennsylvania, Philadelphia, USA
Nicolle Packer, Macquarie University, Sydney, Australia
Xiaohua Shen, Tsinghua University, China
Andrej Shevchenko, Max Planck Institute for Molecular Cell Biology and Genetics, Germany
Chris Bakal, Institute of Cancer Research, UK
Anne K Bendt, National University of Singapore, Singapore
Tunahan Cakir, Gebze Technical University, Turkey
Erin Carlson, University of Minnesota, USA
James Edwards, Saint Louis University, USA
Alex Georgakilas, East Carolina University, USA
Walter Kolch, System Biology Ireland, Dublin, Ireland
Ben Lehner, Center for Genomic Regulation, Spain
Souvik Maiti, Institute of Genomics and Integrative Biology,India
Silke Sperling, Max Planck Institute for Molecular Genetics, Berlin, Germany
Ed Tate, Imperial College London, UK
Ronghu Wu, Georgia Institute of Technology, USA
Katie Lim, Executive Editor, ORCID 0000-0001-9052-1317
James Anson, Deputy Editor
Stella Child, Development Editor
Catherine Hodges, Development Editor
Viktoria Titmus, Editorial Production Manager
Nicola Burton, Publishing Editor
Roxane Owen, Publishing Editor
Alex Rowles, Publishing Editor
Donna Smith, Publishing Editor
Quyen Ngo, Editorial Assistant
Linda Warncke, Publishing Assistant
Journal specific guidelines
The following guidelines are journal specific. For general guidance on preparing an article please visit our Prepare your article and Resources for authors pages, the content of which is relevant to all of our journals.
Post-acquisition processing of data
All image acquisition and processing tools (including their settings) should be clearly stated in the manuscript. The amount of post-acquisition processing of data should be kept to a minimum. Any type of alteration such as image processing, cropping and groupings should be clearly stated in the figure caption and the ESI (clearly describing the process of alteration). Data manipulation (for example, normalisation or handling of missing values) should be given.
Image processing changes should be applied to the entire image as well as all other images it is compared to. Processed images should still represent all the original data (with no data missing) and touch-up tools should be avoided.
For each blot and gel, all positive and negative controls and molecular size markers (for example, protein ladder) should be shown (if not in the main figure at least in the ESI). Important bands should not be cropped in gels and cropped blots should retain at least six band widths above and below the band. If part of a gel is shown in the main text, the full picture of the same uncropped gel should be given in the ESI. High contrast gels and blots are not recommended to avoid masking of additional bands; a grey background is highly encouraged. Only results of comparable experiments should be compared.
Genuine and relevant signals in spectra must not be lost due to image enhancement.
Microscopy images of cells from multiple fields should not be compared but shown as single images (at least in the ESI).
Authors might be asked during peer review to provide the original unprocessed data to the editors/reviewers of the journal.
Readership information
Researchers from industry and academia interested in molecular level research in proteomics, transcriptomics and metabolomics, genomics and other omics science.
Thus the journal will appeal to a wide variety of researchers, but particularly to the folllowing.
- Chemical biologists
- Biological chemists
- Biochemists
- Molecular and structural biologists
- Drug discovery scientists
- Protein chemists
- Bio- and cheminformaticians
- Organic and analytical chemists
Subscription information
Online only 2021: £1,379 / $2,431
*2019 Journal Citation Reports (Clarivate Analytics, 2020)
** Average time from receipt to first decision in 2020
Molecular Omics
- Email:
- Send us an email
- Email:
- Send us an email
Share
Advertisement